"Davis Polk Advises on GRAIL, Inc.'s $325 Million Private Placement to Advance Early Cancer Detection"

"Davis Polk advised placement agents on GRAIL, Inc.'s $325 million private placement of common stock and pre-funded warrants. GRAIL is a healthcare company focused on early cancer detection using advanced technologies. The Davis Polk team included partners and associates from their Northern California and New York offices, providing corporate and intellectual property advice."

Davis Polk & Wardwell LLP advised the placement agents in connection with GRAIL, Inc.’s $325 million private placement of common stock and pre-funded warrants. The transaction involved GRAIL, a healthcare company dedicated to early cancer detection, utilizing advanced technologies such as next-generation sequencing and machine learning to identify multiple cancer types at earlier stages, thereby aiming to alleviate the global burden of cancer. The Davis Polk corporate team included partners Alan F. Denenberg and Beth LeBow, along with associates Sunny Xu and Robb Dehney. Additionally, partner Frank Azzopardi and associates Shreya R. Kundur and Nazli Ungan provided intellectual property advice. Members of the Davis Polk team are based in the Northern California and New York offices.

"Davis Polk Advises on GRAIL, Inc.'s $325 Million Private Placement to Advance Early Cancer Detection"

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads